Tower Research Capital LLC (Trc) Assertio Holdings, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $5.8 Billion
- Q2 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Assertio Holdings, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 20,828 shares of ASRT stock, worth $25,410. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,828
Previous 9,216
126.0%
Holding current value
$25,410
Previous $8,000
212.5%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding ASRT
# of Institutions
114Shares Held
37.2MCall Options Held
755KPut Options Held
39.5K-
Nantahala Capital Management, LLC New Canaan, CT9.27MShares$11.3 Million0.77% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.47MShares$5.45 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.38MShares$2.9 Million0.01% of portfolio
-
Aqr Capital Management LLC Greenwich, CT2.31MShares$2.82 Million0.0% of portfolio
-
Russell Investments Group, Ltd.2.2MShares$2.68 Million0.0% of portfolio
About Assertio Holdings, Inc.
- Ticker ASRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 48,178,200
- Market Cap $58.8M
- Description
- Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing sp...